A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer

Clinical Trials, High Risk Prostate Cancer, Metastatic Castration Resistant Prostate Cancer (MCRPC), Metastatic Castration Sensitive Prostate Cancer (MCSPC), Non-Metastatic Castration Resistant Prostate Cancer (nMCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04586270
Phase: PHASE1
Trial Summary: The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer. – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Taiho Oncology, Inc.
Acronym:

Pin It on Pinterest